IP Library Granted Patent US 7,797,980
Granted Patent B2
US 7,797,980 · App. 11/988,580 · Granted Sep 21, 2010

Method for calibrating blood analysis machines

Assignee: Alifax Holding S.p.A.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,797,980
App. No.
11/988,580
Granted
Sep 21, 2010
Kind
B2
Abstract

A method for calibrating machines suitable to effect an analysis of a blood sample by measuring the erythrocyte sedimentation rate (ESR) and/or aggregation of the red corpuscles, wherein the measurement is effected by exploiting the optical density kinetics obtained from the measurement of the variation in the optical density of the blood sample in an interval of time, to include measuring in which, by the same machine with which the measurement of the optical density is effected on the blood sample, a measurement is effected of the optical density of two latexes, or turbidimetric samples. Each of the two latexes has a known optical density that is reproducible, measurable and different from each other. The method also calibrates in which the difference is calculated between the values of optical density of the latexes as obtained from the measurement performed by the machine and the known values of optical density, to determine at least one correction factor usable to calibrate machine.

Claims (12)

1. A method for calibrating machines to effect an analysis of a blood sample by measuring erythrocyte sedimentation rate (ESR) and/or aggregation of red corpuscles, wherein measurement is performed by exploiting optical density kinetics obtained from measurement of variation in optical density of said blood sample in an interval of time, comprising a measuring step in which, the same machine with which the measurement of the optical density is performed on said blood sample, wherein a first measurement is performed of the optical density of a first of at least two latexes, or turbidimetric samples, having a known optical density that is reproducible and measurable, and wherein a second measurement is performed of the optical density of a second of said at least two latexes having a known optical density that is reproducible, measurable and different from the optical density of said first latex, and a calibration step, in which the difference is calculated between the values of optical density of at least said first and second of said at least two latexes as obtained from the measurements performed by the machine and the known values of optical density, to determine at least one correction factor usable to calibrate said machine.

2. The method as in claim 1 , wherein said optical density kinetics is obtained from a sudden stoppage of flow of said blood sample through a measuring cell.

3. The method as in claim 1 , wherein said correction factor is a value proportional to gain to be assigned to the machine.

4. The method as in claim 1 , wherein said latexes are of natural or synthetic origin.

5. The method as in claim 1 wherein the optical densities of said latexes or of analogous or comparable substances, is substantially independent with respect to temperature and pressure.

6. The method as in claim 1 , wherein during said measuring step, said latexes are analyzed separately in a single calibration process, in order to obtain relative different values of optical density.

7. The method as in claim 1 , wherein during said measuring step, said latexes are analyzed in sequence in a single calibration process, in order to obtain relative different values of optical density.

8. The method as in claim 1 , wherein during said measuring step, the values measured are memorized electronically.

9. The method as in claim 1 , wherein said method is independent of environmental conditions where the machine is located.

10. The method as in claim 1 , wherein the values of optical density of said at least two latexes comprise a minimum and maximum range of variation in optical density caused by said blood sample which is made to flow through a measuring capillary and which flow is suddenly stopped, defining a characteristic curve of optical density of the blood sample.

11. The method as in claim 1 , wherein the optical density measured for the first of said two latexes represents the optical density of the beginning of the optical density kinetics, caused by a sudden stoppage of the flow of said blood sample, and the optical density measured for the second of said two latexes represents the optical density after a pre-fixed measuring time.

12. The method as in claim 1 , wherein during said measuring step, said optical density is measured by emitting from an emitter an electromagnetic wave or a sound wave and by detecting said electromagnetic wave or said sound wave by a detector.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYANCE TYPE PREVIOUSLY RECORDED AT REEL: 045609 FRAME: 0310. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT Recorded Apr 26, 2018
From: ALIFAX HOLDING SPA
To: ALIFAX S.R.L.
Reel/Frame 046022/0763 →
CHANGE OF NAME Recorded Mar 16, 2018
From: ALIFAX HOLDING SPA
To: ALIFAX S.R.L.
Reel/Frame 045609/0310 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2009
From: ALIFAX INTERNATIONAL S.A.
To: ALIFAX S.P.A.
Reel/Frame 022642/0324 →
CHANGE OF NAME Recorded May 5, 2009
From: ALIFAX S.P.A.
To: ALIFAX HOLDING S.P.A.
Reel/Frame 022670/0082 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2008
From: CIOTTI, ALFREDO; GALIANO, PAOLO; CIOTTI, GIUSEPPE
To: ALIFAX INTERNATIONAL S.A.
Reel/Frame 020389/0638 →
Priority Claims (1)
IT UD2005A0118 · Jul 13, 2005 · national
Continuity (1)
Related Publication 20090120157A1 · May 14, 2009